Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07762872
A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSDChifeng Municipal HospitalRecruiting
NCT07762872Recruiting
—
A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in...Chifeng Municipal Hospita...
NCT07762703
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyBreakBio CorpNot Yet RecruitingPhase 1
NCT07762703Not Yet Recruiting
Phase 1
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metasta...BreakBio Corp
NCT07762833
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic DermatitisGalderma R&DNot Yet RecruitingPhase 3
NCT07762833Not Yet Recruiting
Phase 3
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Sub...Galderma R&D
NCT07762248
Impact of Minimally Invasive Endodontic Treatment on the Prognosis of Mandibular Permanent Molars With Necrotic Pulp and Apical PeriodontitisMohamed Ashraf AbdeenNot Yet RecruitingPhase 2
NCT07762248Not Yet Recruiting
Phase 2
Impact of Minimally Invasive Endodontic Treatment on the Prognosis of Mandibular...Mohamed Ashraf Abdeen
NCT07763522
Validation of a Methodology Using Isometric Dynamometer for Ankle STrength Assessment to Quantify LDH-induced ParesisHelsinki University Central HospitalEnrolling By InvitationNot Applicable
NCT07763522Enrolling By Invitation
Not Applicable
Validation of a Methodology Using Isometric Dynamometer for Ankle STrength Asses...Helsinki University Centr...
NCT07764107
Photobiomodulation for Reducing Sedative-Hypnotic Use:Clinical Trial of a Light-Therapy DeviceNational Health Research Institutes, TaiwanNot Yet RecruitingNot Applicable
NCT07764107Not Yet Recruiting
Not Applicable
Photobiomodulation for Reducing Sedative-Hypnotic Use:Clinical Trial of a Light-...National Health Research...
NCT07764003
A Study of Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Response to 2nd-generation H1-AHsHangzhou Highlightll Pharmaceutical Co., LtdNot Yet RecruitingPhase 2
NCT07764003Not Yet Recruiting
Phase 2
A Study of Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Re...Hangzhou Highlightll Phar...
NCT07763912
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fed Study.ADIUMCompletedNot Applicable
NCT07763912Completed
Not Applicable
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitag...ADIUM
NCT07762768
Effect of CSIR-Developed High-Protein, Low-Glycaemic Index Rice on Glycaemic Response in Individuals With PrediabetesCSIR National Institute for Interdisciplinary Science and Technology (NIIST), ThiruvananthapuramNot Yet RecruitingNot Applicable
NCT07762768Not Yet Recruiting
Not Applicable
Effect of CSIR-Developed High-Protein, Low-Glycaemic Index Rice on Glycaemic Res...CSIR National Institute f...
NCT07762313
An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular Conduit in Adolescents With Extremity Arterial Injury.Humacyte, Inc.Not Yet RecruitingPhase 3
NCT07762313Not Yet Recruiting
Phase 3
An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular...Humacyte, Inc.
NCT07764146
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's DiseaseVoyager TherapeuticsNot Yet RecruitingPhase 1
NCT07764146Not Yet Recruiting
Phase 1
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheim...Voyager Therapeutics
NCT07764406
Effect Of Amniotomy In Early Labour On Duration Of LabourIndus Hospital and Health NetworkCompletedNot Applicable
NCT07764406Completed
Not Applicable
Effect Of Amniotomy In Early Labour On Duration Of LabourIndus Hospital and Health...
NCT07763379
THE ROLE OF C-REACTIVE PROTEIN (CRP) IN THE EARLY DIAGNOSIS OF ANASTOMOTIC LEAKAGE FOLLOWING PRIMARY REPAIR IN GASTROINTESTINAL SURGERYSohag UniversityRecruiting
NCT07763379Recruiting
—
THE ROLE OF C-REACTIVE PROTEIN (CRP) IN THE EARLY DIAGNOSIS OF ANASTOMOTIC LEAKA...Sohag University
NCT07763054
Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia PatientsHaikou Affiliated Hospital of Central South University Xiangya School of MedicineRecruiting
NCT07763054Recruiting
—
Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutro...Haikou Affiliated Hospita...
NCT07762469
Diagnostic Performance of a Flexible Penile Monitoring System for EDBin XuNot Yet Recruiting
NCT07762469Not Yet Recruiting
—
Diagnostic Performance of a Flexible Penile Monitoring System for EDBin Xu
NCT07763158
Evaluating the Role of Genicular Artery Embolization in Treatment of Persistent Pain in Patients With Severe Knee OsteoarthritisKing Abdullah International Medical Research CenterRecruitingNot Applicable
NCT07763158Recruiting
Not Applicable
Evaluating the Role of Genicular Artery Embolization in Treatment of Persistent...King Abdullah Internation...
NCT07763795
Effects of BFRT on Glycemic Control, Nerve Conduction, Functional Outcomes and QOL in Individuals With Type 2 DiabetesSuperior UniversityActive Not RecruitingNot Applicable
NCT07763795Active Not Recruiting
Not Applicable
Effects of BFRT on Glycemic Control, Nerve Conduction, Functional Outcomes and Q...Superior University
NCT07762807
Colchicine And Dialysis Patients; a Feasibility StudyGuy's and St Thomas' NHS Foundation TrustRecruitingNot Applicable
NCT07762807Recruiting
Not Applicable
Colchicine And Dialysis Patients; a Feasibility StudyGuy's and St Thomas' NHS...
Result Breakdown
Not yet recruiting10 (50%)
Recruiting6 (30%)
Completed2 (10%)
Enrolling by invitation1 (5%)
Active, not recruiting1 (5%)
not_applicable8 (40%)
Not Specified6 (30%)
Phase 12 (10%)
Phase 32 (10%)
Phase 22 (10%)